Baptist Health Biomedical Research Symposium Evaluation

Please score your agreement with or assessment of the following questions and statements by rating on a scale of 1 to 5, with 5 representing the highest level of satisfaction or agreement. *

Scoring Key: 5=Strongly Agree 4=Agree 3=Neutral 2=Disagree 1=Strongly Disagree

	5	4	3	2	1
The information and/or skills learned will enhance my professional competence or ability.	The information and/or skills learned will enhance my professional competence or ability. - 5	The information and/or skills learned will enhance my professional competence or ability. - 4	The information and/or skills learned will enhance my professional competence or ability. - 3	The information and/or skills learned will enhance my professional competence or ability. - 2	The information and/or skills learned will enhance my professional competence or ability. - 1
This activity conveyed information which will assist me in improving the health and/or treatment outcomes of of my patients.	This activity conveyed information which will assist me in improving the health and/or treatment outcomes of of my patients. - 5	This activity conveyed information which will assist me in improving the health and/or treatment outcomes of of my patients. - 4	This activity conveyed information which will assist me in improving the health and/or treatment outcomes of of my patients. - 3	This activity conveyed information which will assist me in improving the health and/or treatment outcomes of of my patients. - 2	This activity conveyed information which will assist me in improving the health and/or treatment outcomes of of my patients. - 1

How satisfied or dissatisfied were you with the Speaker's effectiveness in addressing the learning objectives? *

Scoring Key: 5=Strongly satisfied 4= Somewhat satisfied 3=Neither satisfied nor dissatisfied 2= Somewhat dissatisfied 1=Strongly dissatisfied NA= Not Applicable

	5	4	3	2	1	NA
ONC201 for H3 K27M Mutant Gliomas - Yazmin Odia, MD	ONC201 for H3 K27M Mutant Gliomas - Yazmin Odia, MD - 5	ONC201 for H3 K27M Mutant Gliomas - Yazmin Odia, MD - 4	ONC201 for H3 K27M Mutant Gliomas - Yazmin Odia, MD - 3	ONC201 for H3 K27M Mutant Gliomas - Yazmin Odia, MD - 2	ONC201 for H3 K27M Mutant Gliomas - Yazmin Odia, MD - 1	ONC201 for H3 K27M Mutant Gliomas - Yazmin Odia, MD - NA
MRI Guided Radiation for Pancreatic Cancer - Adeel Kaiser, M.D.	MRI Guided Radiation for Pancreatic Cancer - Adeel Kaiser, M.D. - 5	MRI Guided Radiation for Pancreatic Cancer - Adeel Kaiser, M.D. - 4	MRI Guided Radiation for Pancreatic Cancer - Adeel Kaiser, M.D. - 3	MRI Guided Radiation for Pancreatic Cancer - Adeel Kaiser, M.D. - 2	MRI Guided Radiation for Pancreatic Cancer - Adeel Kaiser, M.D. - 1	MRI Guided Radiation for Pancreatic Cancer - Adeel Kaiser, M.D. - NA
Distal Radius and Associated Injury: A Translational and Organizing Study - E. Anne Ouellette, M.D.	Distal Radius and Associated Injury: A Translational and Organizing Study - E. Anne Ouellette, M.D. - 5	Distal Radius and Associated Injury: A Translational and Organizing Study - E. Anne Ouellette, M.D. - 4	Distal Radius and Associated Injury: A Translational and Organizing Study - E. Anne Ouellette, M.D. - 3	Distal Radius and Associated Injury: A Translational and Organizing Study - E. Anne Ouellette, M.D. - 2	Distal Radius and Associated Injury: A Translational and Organizing Study - E. Anne Ouellette, M.D. - 1	Distal Radius and Associated Injury: A Translational and Organizing Study - E. Anne Ouellette, M.D. - NA
Does Restoring Constitutional Alignment in TKR improve Patient Outcomes? - Giovanni Paraliticci, M.D.	Does Restoring Constitutional Alignment in TKR improve Patient Outcomes? - Giovanni Paraliticci, M.D. - 5	Does Restoring Constitutional Alignment in TKR improve Patient Outcomes? - Giovanni Paraliticci, M.D. - 4	Does Restoring Constitutional Alignment in TKR improve Patient Outcomes? - Giovanni Paraliticci, M.D. - 3	Does Restoring Constitutional Alignment in TKR improve Patient Outcomes? - Giovanni Paraliticci, M.D. - 2	Does Restoring Constitutional Alignment in TKR improve Patient Outcomes? - Giovanni Paraliticci, M.D. - 1	Does Restoring Constitutional Alignment in TKR improve Patient Outcomes? - Giovanni Paraliticci, M.D. - NA
PE-TRACT Trial (NIH-sponsored Trial on Thrombectomy for Acute Pulmonary Emboli) - Ripal Gandhi, M.D.	PE-TRACT Trial (NIH-sponsored Trial on Thrombectomy for Acute Pulmonary Emboli) - Ripal Gandhi, M.D. - 5	PE-TRACT Trial (NIH-sponsored Trial on Thrombectomy for Acute Pulmonary Emboli) - Ripal Gandhi, M.D. - 4	PE-TRACT Trial (NIH-sponsored Trial on Thrombectomy for Acute Pulmonary Emboli) - Ripal Gandhi, M.D. - 3	PE-TRACT Trial (NIH-sponsored Trial on Thrombectomy for Acute Pulmonary Emboli) - Ripal Gandhi, M.D. - 2	PE-TRACT Trial (NIH-sponsored Trial on Thrombectomy for Acute Pulmonary Emboli) - Ripal Gandhi, M.D. - 1	PE-TRACT Trial (NIH-sponsored Trial on Thrombectomy for Acute Pulmonary Emboli) - Ripal Gandhi, M.D. - NA
RESCU SSO2: Evaluation of Intra-arterial Supersaturated Oxygen Therapy in Acute Myocardial Infarction With Shock - Ramon Quesada, M.D.	RESCU SSO2: Evaluation of Intra-arterial Supersaturated Oxygen Therapy in Acute Myocardial Infarction With Shock - Ramon Quesada, M.D. - 5	RESCU SSO2: Evaluation of Intra-arterial Supersaturated Oxygen Therapy in Acute Myocardial Infarction With Shock - Ramon Quesada, M.D. - 4	RESCU SSO2: Evaluation of Intra-arterial Supersaturated Oxygen Therapy in Acute Myocardial Infarction With Shock - Ramon Quesada, M.D. - 3	RESCU SSO2: Evaluation of Intra-arterial Supersaturated Oxygen Therapy in Acute Myocardial Infarction With Shock - Ramon Quesada, M.D. - 2	RESCU SSO2: Evaluation of Intra-arterial Supersaturated Oxygen Therapy in Acute Myocardial Infarction With Shock - Ramon Quesada, M.D. - 1	RESCU SSO2: Evaluation of Intra-arterial Supersaturated Oxygen Therapy in Acute Myocardial Infarction With Shock - Ramon Quesada, M.D. - NA
Cerebral Neuroprotection and Enhancement in Oxygen Delivery in Acute Stroke: The HEMERA Trial - Italo Linfante, M.D.	Cerebral Neuroprotection and Enhancement in Oxygen Delivery in Acute Stroke: The HEMERA Trial - Italo Linfante, M.D. - 5	Cerebral Neuroprotection and Enhancement in Oxygen Delivery in Acute Stroke: The HEMERA Trial - Italo Linfante, M.D. - 4	Cerebral Neuroprotection and Enhancement in Oxygen Delivery in Acute Stroke: The HEMERA Trial - Italo Linfante, M.D. - 3	Cerebral Neuroprotection and Enhancement in Oxygen Delivery in Acute Stroke: The HEMERA Trial - Italo Linfante, M.D. - 2	Cerebral Neuroprotection and Enhancement in Oxygen Delivery in Acute Stroke: The HEMERA Trial - Italo Linfante, M.D. - 1	Cerebral Neuroprotection and Enhancement in Oxygen Delivery in Acute Stroke: The HEMERA Trial - Italo Linfante, M.D. - NA
The Sleep Smart Trial - Felipe de los Rios la Rosa, M.D.	The Sleep Smart Trial - Felipe de los Rios la Rosa, M.D. - 5	The Sleep Smart Trial - Felipe de los Rios la Rosa, M.D. - 4	The Sleep Smart Trial - Felipe de los Rios la Rosa, M.D. - 3	The Sleep Smart Trial - Felipe de los Rios la Rosa, M.D. - 2	The Sleep Smart Trial - Felipe de los Rios la Rosa, M.D. - 1	The Sleep Smart Trial - Felipe de los Rios la Rosa, M.D. - NA
Insights From a Head and Neck Radiation Oncology Clinic - Noah Kalman, M.D.	Insights From a Head and Neck Radiation Oncology Clinic - Noah Kalman, M.D. - 5	Insights From a Head and Neck Radiation Oncology Clinic - Noah Kalman, M.D. - 4	Insights From a Head and Neck Radiation Oncology Clinic - Noah Kalman, M.D. - 3	Insights From a Head and Neck Radiation Oncology Clinic - Noah Kalman, M.D. - 2	Insights From a Head and Neck Radiation Oncology Clinic - Noah Kalman, M.D. - 1	Insights From a Head and Neck Radiation Oncology Clinic - Noah Kalman, M.D. - NA
SERIES: SEquencing Sacituzumab Govitecan AfteR T-DXd In ER+/HER2 LOW MetaStatic Breast Cancer - Reshma Mahtani, D.O.	SERIES: SEquencing Sacituzumab Govitecan AfteR T-DXd In ER+/HER2 LOW MetaStatic Breast Cancer - Reshma Mahtani, D.O. - 5	SERIES: SEquencing Sacituzumab Govitecan AfteR T-DXd In ER+/HER2 LOW MetaStatic Breast Cancer - Reshma Mahtani, D.O. - 4	SERIES: SEquencing Sacituzumab Govitecan AfteR T-DXd In ER+/HER2 LOW MetaStatic Breast Cancer - Reshma Mahtani, D.O. - 3	SERIES: SEquencing Sacituzumab Govitecan AfteR T-DXd In ER+/HER2 LOW MetaStatic Breast Cancer - Reshma Mahtani, D.O. - 2	SERIES: SEquencing Sacituzumab Govitecan AfteR T-DXd In ER+/HER2 LOW MetaStatic Breast Cancer - Reshma Mahtani, D.O. - 1	SERIES: SEquencing Sacituzumab Govitecan AfteR T-DXd In ER+/HER2 LOW MetaStatic Breast Cancer - Reshma Mahtani, D.O. - NA
Gene Therapy for the Treatment of Radiation-induced Xerostomia - Alessandro Villa, DDS, Ph.D., MPH	Gene Therapy for the Treatment of Radiation-induced Xerostomia - Alessandro Villa, DDS, Ph.D., MPH - 5	Gene Therapy for the Treatment of Radiation-induced Xerostomia - Alessandro Villa, DDS, Ph.D., MPH - 4	Gene Therapy for the Treatment of Radiation-induced Xerostomia - Alessandro Villa, DDS, Ph.D., MPH - 3	Gene Therapy for the Treatment of Radiation-induced Xerostomia - Alessandro Villa, DDS, Ph.D., MPH - 2	Gene Therapy for the Treatment of Radiation-induced Xerostomia - Alessandro Villa, DDS, Ph.D., MPH - 1	Gene Therapy for the Treatment of Radiation-induced Xerostomia - Alessandro Villa, DDS, Ph.D., MPH - NA

Was this course fair, balanced and without commercial bias? *

Yes

No

If you checked "No,” please explain why: *

As a result of my participation in this Symposium, I commit to make the following changes to my clinical practice: *

I will identify patients who could benefit from the emerging technologies and innovation being developed at Baptist Health South Florida to further advance the care of the cancer, cardiac, neurological and orthopedic patients in our community, and initiated the appropriate referral to the specialists.

Not applicable to my practice.

I do not agree with the recommendations presented.

I am retired.

What, if any, new skills/strategies will you apply in your clinical practice? *

What are the potential barriers or obstacles that might prevent you from implementing new strategies you learned at this activity? *

Comments

Name

Attestation *

Choose 1 option

I attest that I have participated in this live symposium in its entirety.

I attest that I have participated in _____ hours of instruction (max 3.5) during this symposium.

hours attestation *

Hours attended

You are here

Baptist Health Biomedical Research Symposium Evaluation